On or around 05/24/2018 (Court's order of dismissal)
Filing Date: January 16, 2018
According to the Complaint, Entellus produces products intended to treat chronic and recurrent sinusitis. The Company has three main product lines: the XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging and Navigation. A significant portion of the Company’s revenues are earned from the XprESS Multi-Sinus Dilation Systems, which include balloon sinus dilation products.
On December 7, 2017, Entellus and Stryker announced that they had entered into a definitive merger agreement (the “Merger Agreement”) pursuant to which Stryker will acquire all of the outstanding shares of common stock of Entellus for $24.00 per share (the “Merger Consideration”). The deal is valued at approximately $662 million.
The Complaint alleges that Defendants have violated Sections of the Exchange Act by causing a materially incomplete and misleading preliminary proxy statement (the “Proxy”) to be filed with the Securities and Exchange Commission (“SEC”) on January 8, 2018. The Proxy recommends that Entellus stockholders vote in favor of a proposed transaction (the “Proposed Transaction”) whereby Entellus is acquired by Stryker.
This case was voluntarily dismissed on May 23, 2018.
Company & Securities Information
Defendant: Entellus Medical, Inc.
Industry: Medical Equipment & Supplies
Headquarters: United States
Ticker Symbol: ENTL
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Pete Horstman, et al. v. Entellus Medical, Inc., et al.